deucravacitinib,Apremilast
bms,amgen
['psoriasis', 'bms', 'bmsnews', 'bristol']
#media: #fda has approved a first-of-its-kind oral option for adults with moderate-to-severe plaque #psoriasis who are candidates for systemic therapy or phototherapy. learn more: 
Global Specialty Care BioPharma